People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.
The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical ...
PHOENIX (AZFamily) — A ketamine-derived nasal spray is now available for the millions of Americans living with severe ...
A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...
Ketamine has been used as an anesthetic before surgeries for decades, but it can also be an option for those struggling with ...
The recent acquisitions by pharmaceutical giants Johnson & Johnson and Bristol Myers Squibb, worth a combined $28billion, ...
However, the spokesperson did say that all health-care practitioners can prescribe the intranasal spray Spravato, which contains ketamine, for treatment-resistant depression, and that no health ...
GH Research's inhaled psychedelic therapy GH001 has shown promise in a mid-stage trial in treatment-resistant depression (TRD ...
An estimated 21 million American adults suffer from clinical depression. © 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes ...